bioRxiv · 10.1101/2020.12.31.424920
Cas9-cleavage sequences in minimal plasmids enhance non-viral genome targeting of CARs in primary human T cells
Abstract
T cell genome editing holds great promise to advance a range of immunotherapies but is encumbered by the dependence on difficult-to-produce and expensive viral vectors. Here we have designed small double-stranded plasmid DNA modified to mediate high-efficiency homologous recombination. The resulting chimeric antigen receptor (CAR)-T cells display a similar phenotype, transcriptional profile and in vivo potency as CAR-T cells generated using adeno-associated viral (AAV) vector. This method should simplify and accelerate the use of precision engineering to produce edited T cells for research and clinical purposes.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jing, R., Jiao, P., chen, j., Meng, X., Wu, X., Duan, Y., Shang, K., Qian, L., Huang, Y., Liu, J., Huang, T., Jin, J., Chen, W., Zeng, X., Yin, W., Gao, X., zhou, c., Sedelain, M., Sun, J.. 2021-01-02. Cas9-cleavage sequences in minimal plasmids enhance non-viral genome targeting of CARs in primary human T cells. https://doi.org/10.1101/2020.12.31.424920
Cite the original work for its findings. Save a collection to share your selection of sources.